report from Biotechnica

Better single-use cross flow techs still needed says GE Healthcare

By Gareth Macdonald contact

- Last updated on GMT

Still work to be done downstream says GE Healthcare expert
Still work to be done downstream says GE Healthcare expert

Related tags: Biotechnology

The biopharmaceutical manufacturing sector needs better cross flow filtration technologies according to GE Healthcare, which says that advances in bioreactor systems have not been matched downstream.

Call for topics

What do you think?

In which areas of the biopharmaceutical manufacturing process are new, better technologies needed?

Is connecting systems provided by different suppliers your biggest headache or do you hanker for improved chromatography systems?

Are today's cell lines good enough or do you think developers could do more?

BioPharma-reporter.com invites readers to suggest topics for future podcasts via the comment box below.

Related news

Show more